Hepatoprotective Effects of Hyaluronic Acid-Preconditioned Bone Marrow Mesenchymal Stem Cells against Liver Toxicity via the Inhibition of Apoptosis and the Wnt/β-Catenin Signaling Pathway

Background: Doxorubicin (DOX) is widely used to treat a variety of malignancies in both adults and children, including those of the bladder, breast, stomach, and ovaries. Despite this, it has been reported to cause hepatotoxicity. The recent discovery of bone marrow-derived mesenchymal stem cells’ (BMSCs) therapeutic effects in the context of liver diseases suggests that their administration plays a part in the mitigation and rehabilitation of drug-induced toxicities. Objectives: This study investigated whether bone BMSCs could reduce DOX-induced liver damage by blocking the Wnt/β-catenin pathway that causes fibrotic liver. Materials and methods: BMSCs were isolated and treated with hyaluronic acid (HA) for 14 days before injection. Thirty-five mature male SD rats were categorized into four groups; group one (control) rats were supplemented with saline 0.9% for 28 days, group two (DOX) rats were injected with DOX (20 mg/kg), group three (DOX + BMSCs) rats were injected with 2 × 106 BMSCs after 4 days of DOX injection, group four (DOX + BMSCs + HA) rats were injected with 0.1 mL BMSCs pretreated with HA after 4 days of DOX. After 28 days the rats were sacrificed, and blood and liver tissue samples were subjected to biochemical and molecular analysis. Morphological and immunohistochemical observations were also carried out. Results: In terms of liver function and antioxidant findings, cells treated with HA showed considerable improvement compared to the DOX group (p < 0.05). Moreover, the expression of inflammatory markers (TGFβ1, iNos), apoptotic markers (Bax, Bcl2), cell tracking markers (SDF1α), fibrotic markers (β-catenin, Wnt7b, FN1, VEGF, and Col-1), and ROS markers (Nrf2, HO-1) was improved in BMSCs conditioned with HA in contrast to BMSCs alone (p < 0.05). Conclusion: Our findings proved that BMSCs treated with HA exert their paracrine therapeutic effects via their secretome, suggesting that cell-based regenerative therapies conditioned with HA may be a viable alternative to reduce hepatotoxicity.

[1]  A. Alisi,et al.  Serum 25‐hydroxyvitamin D and hyaluronic acid levels as markers of fibrosis in patients with chronic liver disease at the main tertiary referral hospital in Ghana: A case‐control study design , 2023, Health science reports.

[2]  S. Elyasi,et al.  None Herbal Agents as Preventive and Therapeutic Measures for Doxorubicin Induced Hepatotoxicity: A Comprehensive Review , 2022, Journal of Pharmaceutical Care.

[3]  A. Hussein,et al.  Retinoic Acid Potentiates the Therapeutic Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells (BM-MSCs) against Cisplatin-Induced Hepatotoxicity in Rats , 2022, Scientia Pharmaceutica.

[4]  Xinxing Wan,et al.  Hyaluronic Acid Facilitates Angiogenesis of Endothelial Colony Forming Cell Combining With Mesenchymal Stem Cell via CD44/ MicroRNA-139-5p Pathway , 2022, Frontiers in Bioengineering and Biotechnology.

[5]  F. Zahran,et al.  Renoprotective effect of bone marrow mesenchymal stem cells with hyaluronic acid against adriamycin- induced kidney fibrosis via inhibition of Wnt/β-catenin pathway. , 2022, International journal of biological macromolecules.

[6]  A. Gökçimen,et al.  Effects of bone marrow‐derived mesenchymal stem cells on doxorubicin‐induced liver injury in rats , 2022, Journal of biochemical and molecular toxicology.

[7]  Shidou Zhao,et al.  Mesenchymal stem cells combined with autocrosslinked hyaluronic acid improve mouse ovarian function by activating the PI3K-AKT pathway in a paracrine manner , 2022, Stem Cell Research & Therapy.

[8]  N. Ali,et al.  Diosmin Alleviates Doxorubicin-Induced Liver Injury via Modulation of Oxidative Stress-Mediated Hepatic Inflammation and Apoptosis via NfkB and MAPK Pathway: A Preclinical Study , 2021, Antioxidants.

[9]  Muhammad Sohail,et al.  Research progress in strategies to improve the efficacy and safety of doxorubicin for cancer chemotherapy , 2021, Expert review of anticancer therapy.

[10]  E. E. El Nashar,et al.  Autophagy Promotes the Survival of Adipose Mesenchymal Stem/Stromal Cells and Enhances Their Therapeutic Effects in Cisplatin-Induced Liver Injury via Modulating TGF-β1/Smad and PI3K/AKT Signaling Pathways , 2021, Cells.

[11]  A. Shokeir,et al.  Possible mechanisms for the renoprotective action of adipose-derived mesenchymal stem cells with CD44-targeted hyaluronic acid against renal ischemia. , 2021, Life sciences.

[12]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[13]  Xuefen Ding,et al.  Clinical application potential of umbilical cord mesenchymal stem cells in chemotherapeutic ovarian failure , 2021 .

[14]  D. Hydock,et al.  Creatine Alleviates Doxorubicin-Induced Liver Damage by Inhibiting Liver Fibrosis, Inflammation, Oxidative Stress, and Cellular Senescence , 2020, Nutrients.

[15]  Md Nazmul Haque,et al.  Role of the CXCR4-SDF1-HMGB1 pathway in the directional migration of cells and regeneration of affected organs , 2020, World journal of stem cells.

[16]  H. Baharvand,et al.  Human embryonic stem cell-derived mesenchymal stem cells improved premature ovarian failure , 2020, World journal of stem cells.

[17]  V. Thongboonkerd,et al.  Effects of Hyaluronic Acid on Calcium Oxalate Crystallization, Growth, Aggregation, Adhesion on Renal Tubular Cells, and Invasion Through Extracellular Matrix , 2020, Current Developments in Nutrition.

[18]  S. Rashid,et al.  Naringenin Regulates Doxorubicin-Induced Liver Dysfunction: Impact on Oxidative Stress and Inflammation , 2020, Plants.

[19]  D. Chu,et al.  Recent Progress of Stem Cell Therapy in Cancer Treatment: Molecular Mechanisms and Potential Applications , 2020, Cells.

[20]  A. Martín-Montalvo,et al.  Therapeutic Potential of Mesenchymal Stem Cells for Cancer Therapy , 2020, Frontiers in Bioengineering and Biotechnology.

[21]  Z. Khan,et al.  Hepatocellular Carcinoma: Molecular Mechanisms and Targeted Therapies , 2019, Medicina.

[22]  M. H. El-Dakdoky,et al.  The impact of mesenchymal stem cells on doxorubicin‐induced testicular toxicity and progeny outcome of male prepubertal rats , 2019, Birth defects research.

[23]  A. Grosu,et al.  The Therapeutic Potential of Mesenchymal Stromal Cells in the Treatment of Chemotherapy-Induced Tissue Damage , 2019, Stem Cell Reviews and Reports.

[24]  Tayyaba Afsar,et al.  Effect of Acacia hydaspica R. Parker extract on lipid peroxidation, antioxidant status, liver function test and histopathology in doxorubicin treated rats , 2019, Lipids in health and disease.

[25]  Yimin Wang,et al.  Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway , 2019, Stem Cell Research & Therapy.

[26]  D. Soave,et al.  Doxorubicin-induced Cardiotoxicity and Cardioprotective Agents: Classic and New Players in the Game. , 2019, Current pharmaceutical design.

[27]  Yixiao Xing,et al.  An In Vitro Comparative Study of Multisource Derived Human Mesenchymal Stem Cells for Bone Tissue Engineering. , 2018, Stem cells and development.

[28]  J. Marin,et al.  Wnt–β-catenin signalling in liver development, health and disease , 2018, Nature Reviews Gastroenterology & Hepatology.

[29]  N. Nicolay,et al.  The current understanding of mesenchymal stem cells as potential attenuators of chemotherapy‐induced toxicity , 2018, International journal of cancer.

[30]  Hae-Ryong Song,et al.  Attenuation of inflammation and cartilage degradation by sulfasalazine-containing hyaluronic acid on osteoarthritis rat model. , 2018, International journal of biological macromolecules.

[31]  G. Storm,et al.  Inhibition of canonical WNT signaling pathway by β-catenin/CBP inhibitor ICG-001 ameliorates liver fibrosis in vivo through suppression of stromal CXCL12. , 2018, Biochimica et biophysica acta. Molecular basis of disease.

[32]  A. Sahebkar,et al.  Protective effects of curcumin against doxorubicin-induced toxicity and resistance: A review. , 2018, Critical reviews in oncology/hematology.

[33]  Yan Li,et al.  VCPA, a novel synthetic derivative of α-tocopheryl succinate, sensitizes human gastric cancer to doxorubicin-induced apoptosis via ROS-dependent mitochondrial dysfunction. , 2017, Cancer letters.

[34]  D. Canale,et al.  Treatment With Human Wharton's Jelly‐Derived Mesenchymal Stem Cells Attenuates Sepsis‐Induced Kidney Injury, Liver Injury, and Endothelial Dysfunction , 2016, Stem cells translational medicine.

[35]  S. Dooley,et al.  TGF‐β signalling and liver disease , 2016, The FEBS journal.

[36]  A. Harraz,et al.  Modulation of renal ischemia/reperfusion in rats by a combination of ischemic preconditioning and adipose-derived mesenchymal stem cells (ADMSCs). , 2016, Canadian journal of physiology and pharmacology.

[37]  Huicai Guo,et al.  Protective effect of berberine on doxorubicin‑induced acute hepatorenal toxicity in rats. , 2016, Molecular medicine reports.

[38]  A. Harraz,et al.  Sildenafil activates antioxidant and antiapoptotic genes and inhibits proinflammatory cytokine genes in a rat model of renal ischemia/reperfusion injury , 2015, International Urology and Nephrology.

[39]  M. Aon,et al.  ErbB2 overexpression upregulates antioxidant enzymes, reduces basal levels of reactive oxygen species, and protects against doxorubicin cardiotoxicity. , 2015, American journal of physiology. Heart and circulatory physiology.

[40]  S. Bello,et al.  Hyaluronic acid effect on adipose-derived stem cells. Biological in vitro evaluation. , 2015, Revista espanola de cirugia ortopedica y traumatologia.

[41]  M. Pines,et al.  The role of iNOS in cholesterol-induced liver fibrosis , 2015, Laboratory Investigation.

[42]  Yixing Chen,et al.  Mesenchymal stem cell–conditioned medium prevents radiation-induced liver injury by inhibiting inflammation and protecting sinusoidal endothelial cells , 2015, Journal of radiation research.

[43]  T. Du,et al.  Microvesicles Derived from Human Wharton's Jelly Mesenchymal Stem Cells Promote Human Renal Cancer Cell Growth and Aggressiveness through Induction of Hepatocyte Growth Factor , 2014, PloS one.

[44]  A. Hussein,et al.  Impact of bone-marrow-derived mesenchymal stem cells on adriamycin-induced chronic nephropathy. , 2014, Canadian journal of physiology and pharmacology.

[45]  A. Shokeir,et al.  Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) and Nrf‐2‐dependent genes by ischaemic pre‐conditioning and post‐conditioning: new adaptive endogenous protective responses against renal ischaemia/reperfusion injury , 2014, Acta physiologica.

[46]  S. Henikoff,et al.  Doxorubicin, DNA torsion, and chromatin dynamics. , 2014, Biochimica et biophysica acta.

[47]  Ada T Feldman,et al.  Tissue processing and hematoxylin and eosin staining. , 2014, Methods in molecular biology.

[48]  W. Guo,et al.  The Role of CD44-Hyaluronic Acid Interaction in Exogenous Mesenchymal Stem Cells Homing to Rat Remnant Kidney , 2014, Kidney and Blood Pressure Research.

[49]  T. Du,et al.  Human Wharton’s jelly-derived mesenchymal stromal cells reduce renal fibrosis through induction of native and foreign hepatocyte growth factor synthesis in injured tubular epithelial cells , 2013, Stem Cell Research & Therapy.

[50]  Jiqi Yan,et al.  Mesenchymal Stem Cells Overexpressing C‐X‐C Chemokine Receptor Type 4 Improve Early Liver Regeneration of Small‐for‐Size Liver Grafts , 2013, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[51]  Y. Anjaneyulu,et al.  A Study on the Toxic Effects of Doxorubicin on the Histology of Certain Organs , 2012, Toxicology international.

[52]  T. Du,et al.  The alleviation of acute and chronic kidney injury by human Wharton's jelly-derived mesenchymal stromal cells triggered by ischemia-reperfusion injury via an endocrine mechanism. , 2012, Cytotherapy.

[53]  K. Lackner,et al.  The lipid lowering drug lovastatin protects against doxorubicin-induced hepatotoxicity. , 2012, Toxicology and applied pharmacology.

[54]  Xiaoyan Zhao,et al.  Protective effects of berberine on doxorubicin-induced nephrotoxicity in mice , 2012, Journal of Translational Medicine.

[55]  T. Wong,et al.  Hyaluronan Regulates Cell Behavior: A Potential Niche Matrix for Stem Cells , 2012, Biochemistry research international.

[56]  G. La Manna,et al.  Mesenchymal Stem Cells in Renal Function Recovery after Acute Kidney Injury: Use of a Differentiating Agent in a Rat Model , 2011, Cell transplantation.

[57]  Madeline A. Lancaster,et al.  Impaired Wnt–β-catenin signaling disrupts adult renal homeostasis and leads to cystic kidney ciliopathy , 2009, Nature Medicine.

[58]  Randall T. Moon,et al.  Proximal events in Wnt signal transduction , 2009, Nature Reviews Molecular Cell Biology.

[59]  P. Cury,et al.  Evaluation of stem cell administration in a model of kidney ischemia-reperfusion injury. , 2007, International immunopharmacology.

[60]  V. Lionetti,et al.  Hyaluronan Mixed Esters of Butyric and Retinoic Acid Drive Cardiac and Endothelial Fate in Term Placenta Human Mesenchymal Stem Cells and Enhance Cardiac Repair in Infarcted Rat Hearts* , 2007, Journal of Biological Chemistry.

[61]  A. Nagler,et al.  Transplantation of Human Hematopoietic Stem Cells into Ischemic and Growing Kidneys Suggests a Role in Vasculogenesis but Not Tubulogenesis , 2006, Stem cells.

[62]  M. Peifer,et al.  Wnt signaling in oncogenesis and embryogenesis--a look outside the nucleus. , 2000, Science.

[63]  Thomas D. Schmittgen,et al.  Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2 2 DD C T Method , 2022 .